Show simple item record

dc.contributor.authorMenon, S
dc.contributor.authorLea, RA
dc.contributor.authorRoy, B
dc.contributor.authorHanna, M
dc.contributor.authorWee, S
dc.contributor.authorHaupt, LM
dc.contributor.authorGriffiths, LR
dc.date.accessioned2017-05-03T15:23:03Z
dc.date.available2017-05-03T15:23:03Z
dc.date.issued2012
dc.date.modified2013-06-14T00:57:00Z
dc.identifier.issn1129-2377
dc.identifier.doi10.1007/s10194-012-0468-z
dc.identifier.urihttp://hdl.handle.net/10072/47674
dc.description.abstractMigraine is a painful and debilitating, neurovascular disease. Current migraine head pain treatments work with differing efficacies in migraineurs. The opioid system plays an important role in diverse biological functions including analgesia, drug response and pain reduction. The A118G single nucleotide polymorphism (SNP) in exon 1 of the l-opioid receptor gene (OPRM1) has been associated with elevated pain responses and decreased pain threshold in a variety of populations. The aim of the current preliminary study was to test whether genotypes of the OPRM1 A118G SNP are associated with head pain severity in a clinical cohort of female migraineurs. This was a preliminary study to determine whether genotypes of the OPRM1 A118G SNP are associated with head pain severity in a clinical cohort of female migraineurs. A total of 153 chronic migraine with aura sufferers were assessed for migraine head pain using the Migraine Disability Assessment Score instrument and classified into high and low pain severity groups. DNA was extracted and genotypes obtained for the A118G SNP. Logistic regression analysis adjusting for age effects showed the A118G SNP of the OPRM1 gene to be significantly associated with migraine pain severity in the test population (P = 0.0037). In particular, G118 allele carriers were more likely to be high pain sufferers compared to homozygous carriers of the A118 allele (OR = 3.125, 95 % CI = 1.41, 6.93, P = 0.0037). These findings suggest that A118G genotypes of the OPRM1 gene may influence migraineassociated head pain in females. Further investigations are required to fully understand the effect of this gene variant on migraine head pain including studies in males and in different migraine subtypes, as well as in response to head pain medication.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.format.extent250387 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoeng
dc.publisherSpringer
dc.publisher.placeItaly
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom513
dc.relation.ispartofpageto519
dc.relation.ispartofissue7
dc.relation.ispartofjournalJournal of Headache and Pain
dc.relation.ispartofvolume13
dc.rights.retentionY
dc.subject.fieldofresearchGenetics
dc.subject.fieldofresearchGenomics
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchcode3105
dc.subject.fieldofresearchcode310509
dc.subject.fieldofresearchcode3202
dc.titleThe human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Medical Science
gro.rights.copyright© The Author(s) 2012. This is a SpringerOpen Access license agreement which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.date.issued2012
gro.hasfulltextFull Text
gro.griffith.authorWee, Shirley S.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record